Dentinger PJ, Swenson CF, Anaizi NH
Each tablet for oral administration contains either 20 mg or 40 mg of famotidine and the following inactive ingredients: hydroxypropyl cellulose, hypromellose, iron oxides, magnesium stearate, microcrystalline cellulose, corn starch, talc, titanium dioxide, and carnauba wax
) INDICATIONS FOR PPI THERAPY The active ingredient in Famotidine Injection, USP is a histamine H 2-receptor antagonist
9% NaCl for injection
96413: Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug: Report for infusions of 16–90 minutes
Intravenous (IV) administration of the drug results in a peak effect within approximately 30 minutes
Intravenous Administration
[51456] stability in both plastic syringes and IV admixtures diluted with 0
CARDIAC rate and rhythm abnormalities may result from the administration of the H 2-receptor antagonists cimetidine and ranitidine
famotidine, levothyroxine); and antibiotics
After intravenous administration, the maximum effect was achieved within 30 minutes
Famotidine (Pepcid) ALL H2 antagonist 2 min 20 mg 5-10 mL NS None H/A, N/V Fentanyl (Sublimaze) ALL Narcotic analgesic Over 2 min 2mcg/kg Do not dilute (small doses) or may dilute with 5 mL NS 0